Latest Financial Disclosure News

Elanor Investors Group reported a $57 million statutory loss for FY25 but is progressing a $125 million recapitalisation with Rockworth Capital Partners to stabilise its balance sheet amid ongoing financial challenges.

Novo Resources Corp. has issued a prospectus offering free New Options to recent placement participants and joint lead managers, aiming to support its exploration projects in Western Australia and Victoria. The options, exercisable at A$0.15 and expiring in three years, could raise significant capital upon exercise, subject to shareholder approval.

OM Holdings has declared a special dividend following the sale of its 26% interest in Ntsimbintle Mining, signalling a strategic return of capital to shareholders.

CVC Limited has completed the settlement of its Laverton property sale, marking the conclusion of a key transaction announced last month.

Elanor Investors Group reported a $24.5 million net loss for the half year to December 2024, grappling with debt covenant breaches and defaults. The group has struck a $125 million recapitalisation agreement with Rockworth Capital Partners to stabilise its balance sheet and pursue growth.

Australis Oil & Gas reported a $24.9 million loss in 2025, driven largely by impairment charges linked to strategic asset transactions. The company secured a major development partner and sold a significant stake in producing wells, enabling full debt repayment and bolstering cash reserves.

Swoop Holdings Limited has reported a net loss for the half-year ended 31 December 2025, with auditors highlighting material uncertainty over the company’s ability to continue as a going concern. The mobile services provider faces operational and financial challenges as it pursues growth in a competitive market.

MA Credit Income Trust reported a strong half-year profit of $19.7 million, exceeding its return target, while successfully completing a $190.5 million capital raise and initiating a strategic buy-back to manage liquidity.

Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

DigiCo Infrastructure REIT reports a robust first half FY26 with a 15% rise in underlying EBITDA and advances its SYD1 data centre expansion, maintaining positive full-year guidance despite currency headwinds.

NAOS Small Cap Opportunities Company Limited reported a remarkable half-year profit surge and declared a steady quarterly dividend, despite portfolio returns lagging the benchmark index.